نتایج جستجو برای: chronic lymphoblastic leukemia

تعداد نتایج: 730181  

Journal: :Casopis lekaru ceskych 1954
V P Choudhry L S Arya R K Marwaha H Pati A K Saraya

Advances in the molecular characterization of leukemic cells have greatly improved the precision of diagnosis and treatment assignment as well as the monitoring of residual disease in both acute lymphoblastic leukemia and acute myeloid leukemia. Currently, specific genetic rearrangements can be identified in as many as 50% of children with either acute lymphoblastic leukemia or acute myeloid le...

Journal: :Cancer research 2006
Suparna Mishra Bin Zhang Jess M Cunnick Nora Heisterkamp John Groffen

Around 20% of patients with acute lymphoblastic leukemia are Philadelphia chromosome positive (Ph-positive acute lymphoblastic leukemia) and express the Bcr/Abl tyrosine kinase. Treatment with the tyrosine kinase inhibitor Imatinib is currently standard for chronic myelogenous leukemia, which is also caused by Bcr/Abl. However, Imatinib has shown limited efficacy for treating Ph-positive acute ...

Journal: :EJHaem 2023

Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID-19) in adults; however, data specific to children with leukemia are limited. High-quality infectious adverse event from the ongoing Children's Oncology Group (COG) standard-risk B acute lymphoblastic leukemia/lymphoma (ALL/LLy) trial, AALL1731, were analyzed provide disease-specific estimate of SARS-CoV-2 infecti...

Journal: :iranian journal of blood and cancer 0

background: environment of basrah is seriously contaminated with chemical leukomogens as a result of recent military conflicts. many studies in the past few years have reported an increase in the incidence of leukemia in basrah. this study was designed to study the risk and pattern of childhood leukemia in basrah, iraq, from 2003 to 2007.materials and methods: this hospital-based cancer registr...

Alemi , Ashraf , Farrokhifar, Majid , Haghi Karamallah , Mojtaba , Zare-Zardini , Hadi ,

Background: Niosomes or Nonionic surfactant vesicles are nano vehicles utilized in drug delivery systems, especially in cancer therapy. In this study, these vesicles were applied as delivery system for anticancer drug, paclitaxel and then, its anticancer activities was compared with free paclitaxel on Human Acute Lymphoblastic Leukemia (ALL) cell line Nalm-6. Materialas and Methods: In this exp...

2016
Imran N Ahmad Salman Assad Muhammad Rahman Haider Ghazanfar

PURPOSE   This study summarizes a four-year experience from the analysis of hematolymphoid malignancies in Pakistani population using a database of six-colored flow cytometry. METHODS A cross-sectional survey of 323 specimens of hematolymphoid malignancies using six-colored flow cytometry (FC) was carried out in Shifa International Hospital, Islamabad, Pakistan from June 2012 to June 2016. Th...

Journal: :Cancer research 1986
L Hashimi C Y Wang A Al-Katib B Koziner

A monoclonal antibody (anti-BL4) recognizing a previously characterized Mr 54,000 glycoprotein (gp54) was developed by immunizing BALB/c mice with cells from a precursor B-cell line (Josh-7). In normal individuals, this antigenic molecule was present on tonsillar B-cells (60-80%) and on a fraction of peripheral blood B-cells (5-25%). BL4 (gp54) expression was investigated in 186 patients with a...

Journal: :journal of medical signals and sensors 0
morteza moradi amin saeed kermani ardeshir talebi

acute lymphoblastic leukemia is the most common form of pediatric cancer which is categorized into three l1, l2, and l3 and could bedetected through screening of blood and bone marrow smears by pathologists. due to being time‑consuming and tediousness of theprocedure, a computer‑based system is acquired for convenient detection of acute lymphoblastic leukemia. microscopic images areacquired fro...

Journal: :gene, cell and tissue 0
mohammad hashemi cellular and molecular research center, zahedan university of medical sciences, zahedan, ir iran; department of clinical biochemistry, school of medicine, zahedan university of medical sciences, zahedan, ir iran; department of clinical biochemistry, school of medicine, zahedan university of medical sciences, zahedan, ir iran. tel: +98-5413235122 majid naderi genetics of non communicable disease research center, zahedan university of medical sciences, zahedan, ir iran; department of pediatrics, school of medicine, zahedan university of medical sciences, zahedan, ir iran ebrahim eskandari nasab genetics of non communicable disease research center, zahedan university of medical sciences, zahedan, ir iran seyed shahaboddin hasani department of clinical biochemistry, school of medicine, zahedan university of medical sciences, zahedan, ir iran simin sadeghi bojd department of pediatrics, school of medicine, zahedan university of medical sciences, zahedan, ir iran mohsen taheri genetics of non communicable disease research center, zahedan university of medical sciences, zahedan, ir iran

conclusions our findings indicated that mdm2 40-bp ins/del polymorphism was not associated with all in our iranian population. further studies with larger sample sizes and diverse ethnicities are required to verify our findings. background the human murine double minute 2 (mdm2), an oncoprotein, is the major negative regulator of p53. objectives the purpose of this study was to evaluate the imp...

Journal: :iranian red crescent medical journal 0
ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran; hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran. email: fatemeh ghaffari hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran roshanak derakhshandeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran arash jalali hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran

conclusions in iran, hsct has been successfully adapted in routine clinical care. recently, new methods such as double cord blood and haploidentical transplantation have been used to treat many life-threatening diseases. results about 78.2% of the patients (2530 of 3237) remained alive between one to 211 months after stem cell transplantation. nearly, 21.8% (707) of our patients died after stem...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید